Skip to main content


Media Coverage

European Biotechs Catch US IPO Fever

4 June 2015
Corporate & Securities partner David Bakst (New York) is quoted in this article regarding the uptick in European biotech/biopharmaceutical companies listing on Nasdaq.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.